Perspective Therapeutics, Inc.
CATX
$2.99
-$0.13-4.17%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.67% | -44.08% | 6.67% | -71.73% | -- |
| Total Depreciation and Amortization | 55.66% | 53.83% | 43.02% | 15.84% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.41% | 71.83% | -54.07% | 8.85% | -- |
| Change in Net Operating Assets | 381.93% | -58.76% | 106.03% | -55.38% | -- |
| Cash from Operations | -3.49% | -45.81% | 7.33% | -584.02% | -124.14% |
| Capital Expenditure | -1,283.53% | -47.29% | 65.27% | 93.30% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 452.25% | -11,197.58% | 127.04% | 66,700.00% | -- |
| Cash from Investing | 252.23% | -1,868.61% | 120.59% | 147.05% | 229.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -15.38% | -8.33% | 18.75% | -- |
| Issuance of Common Stock | 10.34% | 1,546.09% | -100.00% | -64.91% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.36% | 1,548.09% | -103.77% | -66.08% | -99.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 64.75% | 235.92% | 102.35% | 91.89% | -114.16% |